Menu
+
+
+
+
+
+
FDA said on Wednesday that it plans to take steps this quarter to make it difficult for branded drug companies to adopt tactics that attempt to delay generics from coming to market. The agency said the measures will address "potential abuses of the citizen petition process, companies that restrict...
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
